Combination of the MCL1 Inhibitor PRT1419 and SMARCA2 Degrader PRT3789 Shows Combinatorial Benefit in SMARCA4-Deleted Lung Cancer

Norman Fultang, Neha Bhagwat, Diane Heiser, Alexander Grego, Michael Hulse, Venkat Thodima, Koichi Ito, Kris Vaddi, Bruce Ruggeri, Peggy Scherle